Voir l'article sur le site de l'Institut de Biologie Moléculaire et Cellulaire

These three mornings are open to all interested persons. Please contact the organizers (c.sauter[at]unistra.fr).

The IGBMC is a leading research center that drives projects in fundamental biology and biomedicine. It is internationally recognized for its contributions to the fields of eukaryotic gene expression, cell fate and development, for structural analyses of factors involved in these processes, and for the identification of genes involved in human genetic diseases. Currently, it is composed of 44 teams organized in four scientific departments, state-of-the-art core facilities, and support services. IGBMC is the recipient of the French Initiative of Excellence programs and is hosting nodes of several national and European infrastructures. IGBMC is affiliated with Inserm, CNRS and the Université de Strasbourg. It is located on the “Campus d’innovation”, south of Strasbourg, within an ecosystem of biotech companies, some of which are spin-offs of the Institute.

The Director will have to develop an ambitious strategic vision for the institute, fostering scientific excellence and enhancing international visibility. She/he should have demonstrated leadership and management skills and ability to engage productively with a diverse group of individuals at all levels. Experience in collaborating with diverse stakeholders is required, as well as excellent communication skills.

The language of the Institute is English but working knowledge of French would be desirable.
For further information, please contact directeur.igbmc@igbmc.fr.

In 2022, the young scientist also obtained ATIP-Avenir funding to create a team at the IGBMC in the near future.

The subjects covered: Plant Biology, Virology, Immunology, Genetics and Molecular Biology as well as Structural- and Developmental Biology.

A special series is our “Distinguished Lecturer” Symposium – which this year is co- organized with the Cercle Gutenberg.

As in previous years, we co-organize the Immunology Symposium with the Life Science Faculty at the University of Strasbourg.

FEBS Young Scientists Forum, 6-8 July 2023 in Tours

•     https://2023.febscongress.org/ysf-applications

Closing date for registration for the YSF: 8 December 2022

FEBS Congress, 8-12 July 2023 in Tours

Registration is open

•      https://2023.febscongress.org/registration

Young Scientists Forum de la FEB,  les 6-8 juillet 2023 à Tours

See the Article of Théo Brisset, IGBMC

See the Article by Théo Brisset, IGBMC, on Savoir(s)

Prestigious award for promising research in human genetics

Coordinated by the American Society of Human Genetics (ASHG), the Charles Epstein Award for Excellence in Human Genetics Research recognises particularly promising projects by doctoral and post-doctoral students. A total of 18 finalists are selected each year, 9 PhD students and 9 post-docs, with 3 winners in each category.

This prize is a sign of good fortune for the winning scientists, who then go on to recognised research in the field of human genetics. There have been no French finalists for this prize since 2010.

Marianne Lemée, finalist for her research on the regulation of neurodevelopment in autism spectrum disorders

Marianne Lemée arrived at the IGBMC in January 2020 as a Master 1 student and began her thesis on the identification of genes linked to autism in September 2021 at the IGBMC, within the IMCBio programme. This project aims to identify the gene responsible for neurodevelopmental anomalies linked to chromosomal rearrangements on chromosome 1. These abnormalities are responsible for the 1q21.1 syndrome which induces autistic traits in patients who are carriers.
More specifically, Marianne Lemée's research has shown that deregulation of the CHD1L gene, present in the region of the 1q21.1 syndrome, induces neurodevelopmental abnormalities. This research reveals a new key role for this gene during cortical development. The project now focuses on elucidating the regulatory mechanisms of CHD1L in human cell models mimicking neurogenesis.
All of this work will help improve the management and diagnosis of patients with 1q21.1 syndrome, as well as exploring new therapeutic avenues and better understanding the genetics of autism, which affects many people around the world.

Selected as one of the 18 finalists from over 700 applications received, Marianne Lemée has already received a $1,000 grant from the ASHG and an invitation to the conference to be held from 25 to 29 October at the Los Angeles Convention Center. She will defend her project during the final at the Los Angeles Convention Center, which will take place on 25 October 2022.

At the "Amazing biology: from biomolecules to living beings" stand, we will talk to you about covid-19 (What is an antibody? Antibodies, friends or enemies? antigen/antibody tests, sheets, etc.), mosquitoes (discover the development stages of mosquitoes and flies, recognise male/female, mistakes not to make in the garden, etc.), and explore biomolecules on a 3D screen. And let's not forget the virtual reality masks that are back and where you can dive into the heart of the coronavirus.

And for the "Plants at all scales" stand, through 6 fun and interactive workshops, come and discover and explore the fascinating world of plants at various scales of observation.

For more details, don't hesitate to visit the Fête de la Science website!

Savoir(s) | The University of Strasbourg's daily newspaper

Read more about Savoir(s) | Le quotidien de l'Université de Strasbourg

The LabEx MitoCross is a consortium of 6 Strasbourg teams working on various aspects of the functioning and dysfunction of mitochondria, using several fungal, plant and animal models. These studies apply a wide spectrum of techniques including structural biology, biochemistry, cell biology, genetics and genomics. Created in 2012, MitoCross has since 2021 become, as an independent Research Cluster, an integral part of the Interdisciplinary Institute IMCBio and its University Graduate School (EUR) in integrative molecular and cellular biology of the University of Strasbourg.

This call for applications is open to young researchers, from any field of research relating to mitochondria, and having the capacity to lead a research team at the highest scientific level. Proposals relating to the scientific priorities of the LabEx MitoCross will be preferentially considered, as well as those from candidates bringing new skills and/or developing new models. A chair whose theme will be focused on photosynthetic organisms as models will be located at the IBMP. The other chair whose research program will involve any other model, ranging from fungi to humans, will be located at the GMGM. Researchers applying for permanent positions (CNRS / INSERM researcher or lecturer-researcher at the University of Strasbourg) during the recruitment campaigns of 2022 are eligible for this funding program. Applicants are also invited to submit funding requests to other national and international calls (ERC, ANR JCJC, ATIPAvenir, etc.), compatible and cumulative with these research chairs.

 Duration

These chairs are funded for a period of up to four years, with possible extension within the limit of the aid allocated.

 Funding

The aid allocated to each chair is 400 k€. The amount of funding may include the salary of the chair holder and expenses related to the installation and operation of a research team (salary of a post-doctoral fellow or of a technician, purchase of small equipment, etc.), as well as operational costs.

 Contact

Expressions of interest including a curriculum vitae (2 pages maximum) and a brief description of the scientific program (5 pages maximum) should be sent to Ivan Tarassov: i.tarassov[at]unistra.fr and to Laurence Drouard: laurence.drouard[at]ibmp-cnrs.unistra.fr before October 30, 2022.

The complementarities and synergies between the LabEx researchers constitute an attractive training community for the future IMCBio PhD students. Trainees also benefit from outstanding technology infrastructures and platforms to develop high-level research projects in a stimulating and interdisciplinary environment.

If you are a highly motivated candidate of academic excellence and if you want to start an innovative research project in 2022, then click down below to candidate and join the IMCBio graduate school! (from May 23rd to June 24th 2022).

http://imcbio-phdprogram.unistra.fr

Contact: navarroquezada[at]unistra.fr

The StrasRNA Salon is back at the IBMP seminar room this year. In association with the RNA Society, a workshop is organized on May 18th to allow PhD students to present their work to other researchers from IBMP, IBMC and GMGM institutes. The topic is the RNA and all of its features and functions in cells. This year, the plenary conference is given by Ciarán Condon from IBPC in Paris. During the day, PhD students will present their project through 6 « short talks ». A poster session will be organized too. 

Read more

•  An ERC Consolidator Grant, won by Juliette Godin for her project studying translation as a new level of gene regulation during cortical development.
• An ERC Starting Grant, won by Minchul Kim for his project on syncytial cells, cells that have several nuclei. More specifically, he will investigate how these cells develop and what their functions are.

We aim at organizing a 2-days meeting entitled “Symposium on recent developments in cellular electron microscopy”, and dedicated to the latest progresses in the field of cellular electron microscopy at the interface with fluorescent microscopy and structural biology. The meeting is built around 4 scientific sessions, namely volumetric imaging, cryo-electron tomography, correlative light and electron microscopy, and new technological developments. The meeting is for molecular and cellular biologists to have an overview of the latest results and concepts that develop at this interface.

Due to the sanitary situation, vaccination pass and face masks are mandatory to attend the meeting.

Program - Registration

The organizing committee : Yves Gaudin, I2BC - Carine Giovannangeli, AVIESAN - Bruno Robert, CEA - Patrick Schultz, IGBMC

For more information, please visit:

https://www.unistra.fr/communiques-presse/detail-des-communiques-et-dossiers/19612-erc-proof-of-concept-2022-innovation-therapeutique-pour-le-cholangiocarcinome

https://liverstrasbourg.org/press-release/erc-poc-grant-candy/

Interested by joining us? then have a look at the news and application site here: https://imcbio.unistra.fr/blog/

To apply: https://imcbio-phdprogram.unistra.fr/

A tweet was shared by one of the platform managers live from a friendly atmosphere:

https://twitter.com/jmutterer/status/1465691800614719488

Press release